EyeQDirectory

Official company dossier

Augmedix

AI Expert

SaaS Companiesaugmedix.comUS

AI Trust Score, Reviews & Company Verification

Ownership opportunity

Is this your company? Claim the Augmedix profile to verify ownership and manage company-provided details.

Independent company assessment

9.1/10A · Exceptional

36 indexed evidence signals reviewed

AI Comparison

Safe Entity72% Confidence

Based on 5 polled AI models

  • GeminiGoogle DeepMind
    Safe85%Confidence
  • GrokxAI
    Mixed68%Confidence
  • DeepSeekDeepSeek
    Mixed65%Confidence
  • GLMZ.ai
    Safe72%Confidence
Updated Aug 4
Profile not verified by the brand
Unclaimed profile

This profile is waiting for Augmedix

Augmedix has not claimed this ShouldEye profile yet.

Until an authorized representative verifies ownership, ShouldEye AI independently maintains this overview from public records, reviews, regulatory filings, and live trust signals. Nothing on this page has been approved by the brand.

AI-maintained · Not brand-verified

  • Respond to reviews and experiences in your voice
  • Replace this placeholder with your official brand message
  • Take control of how your trust score is presented

Free verification for authorized company representatives

About

Augmedix is a digital health company that uses ambient AI to capture clinician‑patient conversations and automatically generate medical documentation, reducing administrative burden for healthcare providers.

Headquarters
US
EyeQ
EyeQ AI Live

Full intelligence report for Augmedix

High confidence

Augmedix operates with strong accountability, backed by exceptional regulatory compliance and a stellar market reputation that signals broad consumer confidence. Its advertising transparency and customer support practices are solid, though a comparatively lower legal score suggests some room to strengthen corporate documentation or policy clarity. Taken together, these signals paint a picture of a highly reliable, verified company with robust operational safeguards and only minor consumer-facing gaps.

Strengths
  • Provides a clear, accessible process for users to terminate their accounts
  • Offers a 30‑day opt‑out period for mandatory arbitration, preserving the right to litigation
  • Commits to notifying users via email or in‑service messages before changing terms
Key Risks
  • Broad indemnification clause shifts unlimited legal costs to users
  • Company retains unilateral right to terminate accounts at any time, with or without cause and without prior notice
  • Waiver of California Civil Code Section 1542 removes statutory protections for California residents
Domain & infrastructure
Gandi SASDomain registrar
—Domain age
5 assetsVerified assets
Contact & Support
People Behind Augmedix

Public-facing leadership and ownership signals for Augmedix — synthesized from verified profiles and corporate disclosures where available.

M
Manny Krakaris
Chief Executive Officer
R
Rakesh Desai
Chief Technology Officer
A
Anant Desai
Chief Financial Officer